Coronavirus Vaccine: Deal with Serum for Oxford vaccine Thursday | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
Deal with Serum for Oxford vaccine Thursday

Covid-19 in Bangladesh

Abul Kashem
04 November, 2020, 10:35 pm
Last modified: 05 November, 2020, 12:53 am

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong says 'hello' to woo back visitors after Covid
  • US to end Covid-19 emergency declarations on 11 May
  • Covid remains a public health emergency, says WHO

Deal with Serum for Oxford vaccine Thursday

The government will procure this Covid-19 vaccine via the local drug producer, Beximco Pharmaceuticals, the sole supplier of Seram’s vaccine to Bangladesh

Abul Kashem
04 November, 2020, 10:35 pm
Last modified: 05 November, 2020, 12:53 am
Photo: Reuters 
Photo: Reuters 

Bangladesh is going to sign a deal with the Serum Institute of India on Thursday for availing Covidshield, a potential Covid-19 vaccine developed by Oxford.

The government will procure this Covid-19 vaccine via the local drug producer, Beximco Pharmaceuticals, the sole supplier of Seram's vaccine to Bangladesh.

In the initial six months of the first phase, Serum will supply three crore doses of the vaccine – 50 lakh per month – to Bangladesh at a price similar to what India will get at.

When contacted, Health Secretary Md Abdul Mannan told The Business Standard that Serum will manufacture the Oxford-developed vaccine. Bangladesh will ink an agreement with Serum and import vaccine supplies through Beximco.  

Seeking anonymity, an official at Beximco Group said the government will negotiate with Serum on the vaccine price. Advance payment is required for getting the three crore vaccine doses. Beximco will pay that amount and take a bank guarantee against it.

Besides, Beximco will import the vaccine and hand it over to the government while maintaining a cold chain. The government will also give Beximco a commission for the vaccine import purpose. 

Earlier, the Health Service Division sent a proposal to the Prime Minister's Office for approval to import Serum's vaccine through Beximco.

The proposal said the Serum Institute of India, tasked with producing this potential vaccine in India, has agreed to sell the vaccine to Beximco at $4 per dose, according to the health ministry proposal.

Serum offered per dose of its potential vaccine at $5 while the Indian government agreed to pay $4 for it. Bangladesh thinks both Serum and Indian government will eventually agree to keep the per-dose price at $4.

Serum is ready to provide the vaccine doses at the same price, according to health ministry officials.

In the second phase, Bangladesh will avail supplies of vaccine doses at a price similar to what India will get at. The vaccine price might rise or drop during the time.

In the first phase when the vaccine hits the market, frontline health workers and elderly people aged 65 or above will be the priority recipients for the jab.

The big advantage of having the Oxford-developed vaccine is that it can be stored at 2-8°C, and Bangladesh has that storage facility.

The country does not have the capacity to preserve vaccines being developed by other companies such as the United States' (US) Moderna, Pfizer and China's Sinovac at temperatures ranging between -20°C and -70°C.

 

Top News / Health

Serum / Oxford vaccine / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A man stands in front of collapsed buildings following an earthquake in Kahramanmaras, Turkey February 6, 2023. Ihlas News Agency (IHA) via REUTERS ATTENTION EDITORS - THIS PICTURE WAS PROVIDED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. TURKEY OUT. NO COMMERCIAL OR EDITORIAL SALES IN TURKEY.
    Deaths exceed 2,600 as catastrophic quakes ravage Turkey, Syria
  • 30% cos see double-digit growth even in hard times
    30% cos see double-digit growth even in hard times
  • Govt borrowing from commercial banks surges
    Govt borrowing from commercial banks surges

MOST VIEWED

  • Incepta Pharma abandons Covid vaccine plan
    Incepta Pharma abandons Covid vaccine plan
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    Tighter screening at ports urged as new Covid sub-variant BF.7 detected
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    First case of new Covid sub-variant Omicron BF.7 detected in Bangladesh: IEDCR
  • Illustration: Collected
    Genome sequencing reports of Chinese nationals infected with Covid by Sunday: IEDCR
  • Computer image of a betacoronavirus which is the type of virus linked to Covid-19
    4 Chinese nationals detected with Covid at Dhaka airport
  • Omicron BF7: Land ports still left unguarded
    Omicron BF7: Land ports still left unguarded

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong says 'hello' to woo back visitors after Covid
  • US to end Covid-19 emergency declarations on 11 May
  • Covid remains a public health emergency, says WHO

Features

Photo: Collected

Get your partner a lovely present this Valentine's Day

18h | Brands
Pottery Wheel Craft Kit: A creative outlet for little hands

Pottery Wheel Craft Kit: A creative outlet for little hands

18h | Brands
Say it with Colours

Say it with Colours

1d | Mode
Photo: Courtesy

From 'Made in Bangladesh' to 'Designed in Bangladesh'

1d | Panorama

More Videos from TBS

Who will survive? Adani or Hindenburg?

Who will survive? Adani or Hindenburg?

9h | TBS Stories
James Gunn’s 8-10-year plan for the DC Universe

James Gunn’s 8-10-year plan for the DC Universe

9h | TBS Entertainment
LC issues lead to severe shortage of surgical equipment

LC issues lead to severe shortage of surgical equipment

12h | TBS Insight
Stage plays are going on in the digital age

Stage plays are going on in the digital age

17h | TBS Stories

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

3
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

4
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

5
Photo: Collected
Startups

ShopUp secures $30m debt financing to boost expansion, supply chain

6
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]